The prevalence of Helicobacter pylori infection in patients with gastric and duodenal ulcers a 10-year, single-centre experience

被引:7
作者
Serin, Ayfer [1 ]
Tankurt, Ethem [2 ]
Sarkis, Cihat [3 ]
Simsek, Ilkay [4 ]
机构
[1] Ege Univ, Dept Gastroenterol, TR-35100 Izmir, Turkey
[2] Kent Hosp, Dept Gastroenterol, Izmir, Turkey
[3] Balikesir Univ, Dept Gastroenterol, Balikesir, Turkey
[4] Dokuz Eylul Univ, Dept Gastroenterol, Izmir, Turkey
来源
PRZEGLAD GASTROENTEROLOGICZNY | 2015年 / 10卷 / 03期
关键词
Helicobacter pylori; urease test; gastric ulcer;
D O I
10.5114/pg.2015.49685
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Helicobacter pylori (H. pylori) occurs throughout the world and causes gastroduodenal diseases. There is data indicating a change in the prevalence of H. pylori infection worldwide. The prevalence of H. pylori is 80% in Turkey, while it is higher in many developing countries, and the rate of infection varies throughout the world. In many developing countries, the prevalence of infection exceeds 90% by adulthood. Aim: To determine the change in the rate of H. pylori infection in gastric ulcers and duodenal ulcers for a 10-year period in a single centre. Material and methods: The study population included 550 patients (342 in 2004, 208 in 1994) with gastric and duodenal ulcers. Results: In 2004 there were 125 (36.5%) patients with gastric ulcer and 217 patients with duodenal ulcer (64.5%). CLO test positivity was 39.2% in patients with gastric ulcers and 60% in patients with duodenal ulcers. In 1994 there were 208 patients (159 duodenal ulcers, 49 gastric ulcers). Urease test was positive in 74.2% of patients with duodenal ulcer and in 65.2% of patients with gastric ulcer. The decrease in the rate of urease positivity in patients with gastric ulcer was statistically significant (p = 0.01) during this 10-year period. Conclusions: In the present study we found that the urease positivity decreased significantly in patients with gastric ulcer between 1994 and 2004.
引用
收藏
页码:160 / 163
页数:4
相关论文
共 17 条
  • [1] Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment
    Chan, FKL
    Graham, DY
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (10) : 1051 - 1061
  • [2] Helicobacter pylori
    Dunn, BE
    Cohen, H
    Blaser, MJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) : 720 - +
  • [3] Helicobacter in the developing world
    Frenck, RW
    Clemens, J
    [J]. MICROBES AND INFECTION, 2003, 5 (08) : 705 - 713
  • [4] CAMPYLOBACTER-PYLORIDIS, GASTRITIS, AND PEPTIC-ULCERATION
    GOODWIN, CS
    ARMSTRONG, JA
    MARSHALL, BJ
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (04) : 353 - 365
  • [5] GRAHAM DY, 1993, GASTROINTESTINAL DIS, P698
  • [6] Gulersoy Ozaydin AN, 2007, TURHEP TURKIYE HELIK
  • [7] Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea
    Kim, JH
    Kim, HY
    Kim, NY
    Kim, SW
    Kim, JG
    Kim, JJ
    Roe, IH
    Seo, JK
    Sim, JG
    Ahn, H
    Yoon, BC
    Lee, SW
    Lee, YC
    Chung, IS
    Jung, HY
    Hong, WS
    Choi, KW
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (09) : 969 - 975
  • [8] LARKAI EN, 1987, AM J GASTROENTEROL, V82, P1153
  • [9] CHILDHOOD LIVING-CONDITIONS AND HELICOBACTER-PYLORI SEROPOSITIVITY IN ADULT LIFE
    MENDALL, MA
    GOGGIN, PM
    MOLINEAUX, N
    LEVY, J
    TOOSY, T
    STRACHAN, D
    NORTHFIELD, TC
    [J]. LANCET, 1992, 339 (8798) : 896 - 897
  • [10] HELICOBACTER-PYLORI INFECTION AND THE RISK FOR DUODENAL AND GASTRIC-ULCERATION
    NOMURA, A
    STEMMERMANN, GN
    CHYOU, PH
    PEREZPEREZ, GI
    BLASER, MJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) : 977 - 981